PH20494A - Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosis - Google Patents
Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosisInfo
- Publication number
- PH20494A PH20494A PH26589A PH26589A PH20494A PH 20494 A PH20494 A PH 20494A PH 26589 A PH26589 A PH 26589A PH 26589 A PH26589 A PH 26589A PH 20494 A PH20494 A PH 20494A
- Authority
- PH
- Philippines
- Prior art keywords
- arteriosclerosis
- prophylaxis
- secretion inhibitors
- prolactin secretion
- prolactin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8030228 | 1980-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH20494A true PH20494A (en) | 1987-01-21 |
Family
ID=10516153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH26589A PH20494A (en) | 1980-09-18 | 1981-12-07 | Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosis |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5782317A (en) |
AU (1) | AU7544281A (en) |
BE (1) | BE890369A (en) |
IT (1) | IT1210577B (en) |
PH (1) | PH20494A (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8426922D0 (en) * | 1984-10-24 | 1984-11-28 | Sandoz Ltd | Galenic formulation |
US5668155A (en) * | 1988-05-10 | 1997-09-16 | The General Hospital Corporation | Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
US5344832A (en) * | 1990-01-10 | 1994-09-06 | The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College | Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
US5700800A (en) * | 1988-05-10 | 1997-12-23 | Ergo Science Incorporated | Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound |
US5468755A (en) * | 1988-05-10 | 1995-11-21 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Therapeutic process for the treatment of the pathologies of Type II diabetes |
US6004972A (en) * | 1988-05-10 | 1999-12-21 | The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College | Therapeutic process for the treatment of the pathologies of type II diabetes |
US5006526A (en) * | 1988-10-17 | 1991-04-09 | Louisiana State University | Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis |
CA2030174C (en) * | 1990-01-10 | 1996-12-24 | Anthony H. Cincotta | Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates |
IL112106A0 (en) * | 1993-12-22 | 1995-03-15 | Ergo Science Inc | Accelerated release composition containing bromocriptine |
US5565454A (en) * | 1995-05-31 | 1996-10-15 | Ergo Science, Incorporated | Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions |
US20010016582A1 (en) | 1997-04-28 | 2001-08-23 | Anthony H. Cincotta | Method and composition for the treatment of lipid and glucose metabolism disorders |
-
1981
- 1981-09-16 BE BE1/10317A patent/BE890369A/en not_active IP Right Cessation
- 1981-09-17 JP JP56147731A patent/JPS5782317A/en active Pending
- 1981-09-17 AU AU75442/81A patent/AU7544281A/en not_active Abandoned
- 1981-09-18 IT IT8149328A patent/IT1210577B/en active
- 1981-12-07 PH PH26589A patent/PH20494A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IT8149328A0 (en) | 1981-09-18 |
AU7544281A (en) | 1982-03-25 |
JPS5782317A (en) | 1982-05-22 |
BE890369A (en) | 1982-03-16 |
IT1210577B (en) | 1989-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3175201D1 (en) | Aminothiadiazoles as gastric secretion inhibitors | |
GB2091858B (en) | Surface treatment of objects | |
DE3176344D1 (en) | Improvements in the replacement of mains | |
PT72914A (en) | Beta-lactam compounds their preparation and use | |
ZA816242B (en) | Use of pyridoxine alfa-ketoglutarate in the prophylaxis of hyperlacticacidaemia | |
GB8430707D0 (en) | Restoration of timber components | |
PH20494A (en) | Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosis | |
EP0048264A4 (en) | Dental prophylaxis compositions and their use. | |
GB2074853B (en) | Articles of furniture | |
JPS5711627A (en) | Polisher | |
PH15001A (en) | Prolactin secretion inhibitors | |
GB2081603B (en) | Surface dressing | |
GB8323805D0 (en) | Article of furniture | |
DE3162049D1 (en) | Method for the preparation of 2-halo-3-sulfonyl-acrylonitriles and their use | |
GB2075352B (en) | Equipment for the delivery of slurry and refinement during delivery | |
GB2070592B (en) | -lactamase inhibitor | |
AU554021B2 (en) | Use of pyridoxine alfa-ketoglutarate in the prophylaxis of hyperlacticacidaemia | |
ZA816717B (en) | Compositions and use | |
DE3276758D1 (en) | Use of (co)polytetramethylene-adipamide articles | |
ZA812834B (en) | Aminothiadiazoles as gastric secretion inhibitors | |
JPS5771851A (en) | Manufacture of kiln furniture | |
JPS56169003A (en) | Nanufacture of plywood | |
JPS56163623A (en) | Polisher | |
DE3170987D1 (en) | Dental prophylaxis compositions and their use | |
KR840000615Y1 (en) | Cue |